Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Get the latest international news and world events from around the world.

Log in for authorized contributors

Researchers uncover the earliest stages of human placenta formation

A gene that turns on very early in embryonic development could be key to the formation of the placenta, which provides the developing fetus with what it needs to thrive during gestation.

The placenta provides all of the nutrition, oxygen and antibodies that a developing human fetus needs to thrive throughout gestation. The temporary organ begins to form within six to 12 days after conception, just as the embryo implants itself in the lining of the uterus. Failure of the placenta to form correctly is the second leading cause of miscarriage during early pregnancy, after genetic abnormalities of the fetus that are incompatible with life.

However, the initial stages of placental formation have remained a mystery due to ethical considerations and technical constraints on studying the process in humans.

Dengue vaccine gains first major approval

The world’s first single-dose vaccine to prevent dengue fever has been approved for licensure in one of the largest countries affected by the disease, following 16 years of research contributions by scientists at the University of Vermont (UVM) Vaccine Testing Center, in partnership with the U.S. National Institutes of Health (NIH) and the Johns Hopkins Bloomberg School of Public Health (JHSPH).

Dengue is the most common mosquito-borne disease worldwide, with nearly half the world’s population living in places with the risk of dengue. Along with high fever and severe muscle and bone pain, the virus can lead to shock, bleeding, and death.

With more than 100 million cases reported annually, dengue poses a growing risk throughout the globe, including in the United States. Brazil recorded 5.9 million cases of dengue and more than 6,000 deaths in 2024.

Machine learning reveals how disordered protein regions contribute to cancer-causing condensates

Fusion oncoproteins arise when a gene fuses with another gene and acquires new abilities. Such abilities can include the formation of biomolecular condensates, “droplets” of concentrated proteins, DNA or RNA.

The abnormal molecular condensates formed by fusion oncoproteins can disrupt cellular functions and drive cancer development, but the specific protein features behind this process remain unclear.

Scientists at St. Jude Children’s Research Hospital studied intrinsically disordered regions, unstructured protein segments that are often involved in condensate formation, to determine if they drive fusion oncoproteins to form condensates. They trained a machine learning model, called IDR-Puncta ML, with experimental data from intrinsically disordered regions in fusion oncoproteins to predict the behavior of other such regions.

Novel application of punch excision therapy in the treatment of keloids: A systematic review

Keloids are fibroproliferative disorders of the skin marked with elevated interleukin-6 and transforming growth factor-beta, causing pain, pruritus, and decreased quality of life.1 Punch excision therapy is emerging as a simple, quick, and accessible treatment option for keloid management. This review summarizes the current evidence on the efficacy and safety of punch excision therapy in keloid management.

Poor kidney health linked to higher levels of Alzheimer’s biomarkers in blood

People with impaired kidney function have higher levels of Alzheimer’s biomarkers in their blood, but not an increased risk of dementia, according to a study published in Neurology.

The study does not prove that poor kidney function causes higher levels of Alzheimer’s biomarkers in the blood, it only shows an association.

Kidneys remove waste and toxins from the blood, which are then excreted in urine.

Both total and partial knee replacements deliver lasting benefits at 10 years, clinical trial finds

New research from a randomized clinical trial provides the strongest long-term evidence yet comparing partial (PKR) and total (TKR) knee replacements for patients with osteoarthritis. Published in The Lancet Rheumatology, the study shows both PKR and TKR being equally effective and offering similar clinical outcomes.

In 2019, the Total or Partial Knee Arthroplasty Trial (TOPKAT) study, led by researchers at NDORMS, found that after 5 years, partial knee replacement (PKR) showed similar, if not better, outcomes than total replacement (TKR). But the research horizon was extended to ten years to study whether the longer-term quality of life outlook for patients could be assessed.

Now, with 10 years of data, researchers have found that patients who underwent PKR and TKR had similar long-term pain relief, function, and quality of life outcomes.

/* */